We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Cellectis Acquires Assets from Cyto Pulse Sciences Inc.

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Cellectis Acquires Assets from Cyto Pulse Sciences Inc."

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
Cellectis has announced that it has acquired all the assets of Cyto Pulse Sciences Inc., a US-based company specializing in the development, manufacture and commercialization of electroporation technology and equipment.

Electroporation is a very efficient way to allow molecules such as meganucleases to enter any type of cells, with applications ranging from research and bioproduction to agriculture and therapeutics.

The transaction value of $2.2 million was paid in cash and closed on September 2, 2010.